Pharmacological inhibition of ezrin reduces proliferative and invasive phenotype in acute lymphoblastic leukemia cells.
Lipreri da Silva JC, Lima K, Ede B, Lazarini M, Vicari HP, Nogueira FL, Clayton NS, Pinnell K, Silva WFD, Velloso EDRP, Bendit I, Costa-Lotufo LV, Rego EM, Ridley AJ, Machado-Neto JA.
Lipreri da Silva JC, et al. Among authors: lima k.
Eur J Pharmacol. 2024 Nov 29;987:177161. doi: 10.1016/j.ejphar.2024.177161. Online ahead of print.
Eur J Pharmacol. 2024.
PMID: 39615869